Universe Pharmaceuticals INC
corporate_fare Company Profile
Universe Pharmaceuticals INC (NASDAQ:UPC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 10 items for UPC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-01, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for UPC spans 6-K, SCHEDULE 13D, 20-F.
Recent high-impact activity:
- Universe Pharmaceuticals Seeks Shareholder Approval for 1-for-10 Reverse Split to Regain Nasdaq Compliance
- Universe Pharmaceuticals closes $10.75M Best Praise acquisition, issuing 4.38M shares
- Universe Pharma Posts $9M Revenue, $1.6M Loss; Unveils $10.75M All-Stock Deal
- Universe Pharmaceuticals to Acquire Best Praise for $10.75M in Stock, Causing Over 1000% Dilution
- Universe Pharmaceuticals to Acquire 100% of Best Praise International
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for UPC, detected from its recent SEC filings · based on capital-structure filings through 2026-05-14.
Significant Share Grant to CEO · Material Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
UPC files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.